Jefferies Financial Group (JEF) Investor Meeting summary
Event summary combining transcript, slides, and related documents.
Investor Meeting summary
20 Oct, 2026Financial performance and capital allocation
LTM Q3'26 net revenue was $8.5bn; net earnings exceeded $935m and continuing-operations ROTE was 13.1%, up 726 bps since 2019.
Investment Banking and Capital Markets generated over 90% of LTM revenue; fee-based revenues and client businesses drove 87% of growth since 2019.
Investment Banking and Capital Markets revenue rose from $4.5bn in 2023 to $7.8bn; pretax profit increased from $0.5bn to $1.3bn and margin expanded from 11% to 16%+.
Adjusted segment revenue grew 75% since 2023 while adjusted non-comp expenses rose 37%; the adjusted non-comp ratio declined from 30% to 24%.
Capital returned since Nov. 2018 totaled $6.4bn and diluted shares fell 24%; 2026 dividends and repurchases approached 11% of tangible book value in the first 10 months.
Strategy and earnings outlook
Client-first, people-led strategy remains focused on building an independent, full-service global investment bank; platform scale supports higher margins and operating leverage.
Priorities include maturing the platform, gaining share, expanding margins and realizing returns on prior investment; the bulk of investment-banking hiring has passed, with targeted hiring continuing.
Like-for-like revenue is expected to generate comp leverage from 2027; management sees continued investment-banking and equities opportunities, improving fixed income and more consistent asset-management results.
Returns and EPS are expected to improve in 2027 and beyond; management cited current 13% ROTE and an aspiration toward mid-teens, without a promise, and no meaningful change in balance-sheet leverage appetite.
Merchant-bank simplification and asset monetizations are nearing completion; exits from Tessellis, Stratos and two residual businesses are intended to remove earnings drag and redeploy capital.
Investment banking and equities growth
Global rankings include #5 in advisory and ECM; FY YTD Sep. 2026 top-six fee share was 4.3%, up 160 bps since 2019.
Advisory and ECM revenue totaled $4.0bn, including $2.7bn advisory and $1.3bn ECM; the franchise spans sponsor and corporate M&A and global ECM.
Sponsor sell-side share for deals under $1bn reached 7.5%, ranking second; large-cap sponsor M&A share was 7.4%, ranking third. Biopharma ECM share reached 14.4%, ranking first.
Equities LTM Q3'26 revenue reached a record $2.3bn; international revenue was 44% of global S&T, while prime-services balances grew ~4x and derivatives revenue ~5x since 2022.
SMBC collaboration supports a Jan. 1, 2027 Japan equities launch, combining coverage, research, capital, technology and products; the goal is a #1 franchise. Jointly covered sponsor share grew >3x.
Latest events from Jefferies Financial Group
- A $19.9B liquidity pool and low Level 3 exposure anchor the credit profile.JEF
Corporate presentation - Strong financial results, robust liquidity, and investment-grade ratings support continued growth.JEF
Corporate presentation - Record Advisory and Equities lifted Q3 net revenues 8.5% to $2.222B.JEF
Q3 2026 - Q2 2026 net revenues surged 35% year-over-year, led by record investment banking and equities results.JEF
Q2 2026 - Reports strong liquidity, low leverage, and $7.8B in annual net revenues with stable credit ratings.JEF
Corporate presentation - Record earnings and revenues driven by investment banking and equities; Tessellis sale agreed.JEF
Q1 2026 - Shareholders will vote on directors, executive pay, auditor, and a key capital structure amendment.JEF
Proxy Filing - Record growth, global expansion, and SMBC partnership drive market leadership and optimism.JEF
Investor Meeting - Record growth, market share gains, and capital returns drive future global momentum.JEF
Investor Meeting